Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM Study
Crossref DOI link: https://doi.org/10.1186/s12876-017-0604-y
Published Online: 2017-04-04
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Nagahori, Masakazu
Kochi, Shuji
Hanai, Hiroyuki
Yamamoto, Takayuki
Nakamura, Shiro
Omuro, Soji
Watanabe, Mamoru
Hibi, Toshifumi
Funding for this research was provided by:
Kyorin Pharmaceutical Co., Ltd.
